arrow
M

Michele Matarazzo

HM Hospitales
H指数:17
被引数:985

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

From Skull Density Ratio-based eligibility to efficiency-informed planning: Predictive modeling of thermal response in MR-guided focused ultrasound

从基于颅骨密度比的适用性到效率导向的规划:MR引导聚焦超声热响应的预测建模

2026-09-130
OAAI
Dyskinesias induced by focused ultrasound subthalamotomy in Parkinson’s disease are associated with better patient impression of change

帕金森病患者经聚焦超声下丘脑切开术诱发的运动障碍与患者对变化的更好印象相关

2026-09-080
PRE
Functional segregation in Parkinson’s disease

帕金森病中的功能分离

2026-07-150
OA
Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial

灵活剂量塔瓦帕多龙治疗帕金森病的安全性、耐受性和有效性(TEMPO-2):一项3期、随机、安慰剂对照、双盲试验

2026-07-150
PRE
Voice disturbances in Parkinson's disease and essential tremor: A cross-sectional acoustic comparison

帕金森病和特发性震颤中的发声障碍:一项横断面声学比较

2026-07-090
PRE
Co‐ and Multi‐Pathologies in Parkinson's Disease: An International Parkinson and Movement Disorder Society Scientific Issues Committee Review

帕金森病中的共病与多病理学:国际帕金森与运动障碍学会科学问题委员会综述

2026-05-220
OA
RAB32-Linked Parkinson's Disease: Deep Phenotyping, MDSGene Literature Review, and Application of SynNeurGe Criteria

RAB32-相关帕金森病:深度表型分析、MDSGene文献综述及SynNeurGe标准的应用

2025-10-010
OAAI
Genetic and Epidemiological Insights into RAB32-Linked Parkinson's Disease

RAB32-Linked帕金森病的遗传和流行病学见解

2024-10-260
OA
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study

基因靶向试验时代基因检测的相关性: 罗斯托克帕金森病研究

BRAIN
IF11.7
2024-08-018
OAAI
Nigrostriatal blood-brain barrier opening in Parkinson's disease

帕金森病黑质纹状体血脑屏障开放

2024-05-172
PRE
Misfolded protein deposits in Parkinson's disease and Parkinson's disease-related cognitive impairment, a [11C]PBB3 study

帕金森氏病和帕金森氏病相关认知障碍中的错误折叠蛋白沉积,一项 [11C]PBB3研究

2024-05-033
OAAI